Professional Documents
Culture Documents
Karen M. Puopolo, M.D. Ph.D., Mark L. Hudak, M.D., David W. Kimberlin, M.D., James Cummings, M.D. Management of Infants Born to Mothers with COVID-19 Date of Document: April 2, 2020. American Academy of Pediatrics
Committee on Fetus and Newborn, Section on Neonatal Perinatal Medicine, and Committee on Infectious Diseases
Emerging Microbes & Infections
2020, VOL. 9
Detectable 2019-nCoV viral RNA in blood is a
strong indicator for the further clinical severity
Chen W, Lan Y, Yuan X, Deng X, Li Y, Cai X, Li L, He R, Tan Y, Deng X, Gao M. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerging microbes & infections. 2020 Jan 1;9(1):469-73.
Vertical Transmission of Coronavirus Disease
19 (COVID-19) from Infected Pregnant
Mothers to Neonates: A Review
• A total of 31 infected pregnant mothers with COVID-19 were
reported.
• No COVID-19 infection was detected in their neonates or
placentas.
• No evidence for intrauterine transmission of COVID-19 from
infected pregnant women to their fetuses
Antibodies in Infants Born to Mothers
With COVID-19 Pneumonia
• Neonatal throat swabs and blood samples all had negative RT-PCR test results.
• All 6 infants had antibodies detected in their serum.
Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, Long X. Antibodies in infants born to mothers with COVID-19 pneumonia. Jama. 2020 Mar 26.
Antibodies in Infants Born to Mothers
With COVID-19 Pneumonia
Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, Long X. Antibodies in infants born to mothers with COVID-19 pneumonia. Jama. 2020 Mar 26.
Clinical characteristics and intrauterine vertical transmission
potential of COVID-19 infection in nine pregnant women:
a retrospective review of medical records
Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao D, Xu D, Gong Q, Liao J. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical
records. The Lancet. 2020 Mar 7;395(10226):809-15.
Birth Mode
Rekomendasi Perkumpulan Obstetri Ginekologi Indonesia (POGI) mengenai kesehatan ibu pada Pandemi Covid 19
Recommended Personal Protective
Equipment (PPE) - CDC
• The minimum PPE recommended:
• A single pair of disposable examination gloves
• Disposable isolation gown or single-
use/disposable coveralls
• Any NIOSH-approved particulate respirator
(i.e., N-95 or higher-
level respirator); facemasks are an acceptable
alternative until the supply chain is restored
• Eye protection (i.e., goggles or disposable
face shield that fully covers the front and
sides of the face).
https://www.cdc.gov/coronavirus/2019-ncov/downloads/guidance-law-enforcement.pdf
Setting up of a birthing room
(for spontaneous birth as well as Caesarean Section)
OR
Airway Management
• Clearing the airway by suctioning could generate aerosols
• Should use adequate PPE!
• A neonate who requires positive pressure ventilation (PPV), the
resuscitation is performed as per AAP and NRP recommended
parameters and target saturations with supplemental oxygen.
• Personnel involved in the placement of an advanced airway, such
as an endotracheal tube
• take precautions (N95 masks, face shields/goggles, and
double glove)
• The most experienced provider should perform intubation and
other procedures to limit aerosol generation.
Chandrasekharan P, Vento M, Trevisanuto D, Partridge E, Underwood MA, Wiedeman J, Katheria A, Lakshminrusimha S. Neonatal Resuscitation and Postresuscitation Care of Infants Born to Mothers with Suspected or Confirmed
SARS-CoV-2 Infection. American Journal of Perinatology. 2020 Apr 8.
Neonatal Resuscitation
COVID-19 – Guideline Neonatal care of infants born to women with suspected or confirmed COVID-19. Canberra Health Services
Neonatal Transport
Transport to NICU (if required)
• If ongoing invasive ventilation is required à the flow will be
stopped, then disconnect infant from respiratory support
and with the HME filter to remain on the ETT during this
activity.
• If ongoing NIV (CPAP) is required, the flow will be stopped
with CPAP interrupted, the baby will be “carried” from
resuscitaire to isolette and shuttle or mansel in the “green
or amber zone”
• If using bubble CPAP for transport on the shuttle, a viral
filter (preferred) (or HME filter) should be used on the
expiratory limb of the CPAP
• The team transporting the newborn to keep PPE on,
changing gloves and any other visibly contaminated PPE
COVID-19 – Guideline Neonatal care of infants born to women with suspected or confirmed COVID-19. Canberra Health Services
Newborn Care Baby was given face shield to
avoid droplet infections (for
• Neonates born to women with COVID-19 or with testing for COVID-19 newborn with pending
pending at the time of delivery à considered as persons under laboratory result)
investigation (PUIs) for infection
• Isolate the baby from infant born from non COVID-19 mother
• Temporary separation of mother and newborn
• minimize the risk of postnatal infant infection from maternal respiratory
secretions.
• Set wiped containers in a rack or on a tray to dry (wet to dry ensures time for viricidal effect) before storing in refrigerators or freezers
• For hospital wards/neonatal intensive care units, separate bins for each infant in the same refrigerator are fine once the containers have been wiped down
• Resume usual protocol
Marinelli KA, Lawrence RM. Safe Handling of Containers of Expressed Human Milk in all Settings During the SARS-CoV-2 (COVID-19) Pandemic. Journal of Human Lactation. 2020 Apr 3:0890334420919083.
Newborn Viral Testing
Ideally, neonates should be tested for SARS- CoV-2 infection
using available molecular assays
• Especially require prolonged neonatal intensive care
• If not available: clinical monitoring only.
1. Real Time Polymerase Chain Reaction (RT-PCR) à considered the gold standard
2. Molecular assay testing: at 24 hours of age
3. Repeat testing at 48 hours of age
• For well newborns who will be discharged à may consider not obtaining this test
4. At each test, consider using swabs of throat and nasopharynx (+rectal swab)
5. For infants who are positive on their initial PCR testing
• follow-up testing of combined specimens from the throat and nasopharynx
• at 48-72 hour intervals until two consecutive negative tests.
Karen M. Puopolo, M.D. Ph.D., Mark L. Hudak, M.D., David W. Kimberlin, M.D., James Cummings, M.D. Management of Infants Born to Mothers with COVID-19 Date of Document: April 2, 2020. American Academy of Pediatrics
Committee on Fetus and Newborn, Section on Neonatal Perinatal Medicine, and Committee on Infectious Diseases
Alur Pemeriksaan rapid test
SARS-CoV2 (COVID-19)
Usulan PDS PatKlin
Post Discharge Care
• Infants determined to be infected by • Infants with negative SARS-CoV-2
molecular testing (or whose status cannot molecular testing should be discharged to
be determined due to lack of testing), but the care of a designated healthy (non-
with no symptoms of COVID-19 infected) caregiver.
Karen M. Puopolo, M.D. Ph.D., Mark L. Hudak, M.D., David W. Kimberlin, M.D., James Cummings, M.D. Management of Infants Born to Mothers with COVID-19 Date of Document: April 2, 2020. American Academy of Pediatrics
Committee on Fetus and Newborn, Section on Neonatal Perinatal Medicine, and Committee on Infectious Diseases
Maternal visitation for infants requiring
ongoing hospital care
Mothers with COVID-19 should not visit infants requiring NICU until:
• Resolution of fever without the use of antipyretics for at least 72 hours and
• Improvement (but not full resolution) in respiratory symptoms and
• Negative results of a molecular assay for detection of SARS-CoV-2 from at least two consecutive
nasopharyngeal swab specimens collected ≥24 hours apart
Conclusion
COVID-19 – Guideline Neonatal care of infants born to women with suspected or confirmed COVID-19. Canberra Health Services
Precautions in Delivery Room for Newborn
Baby born from mother with suspected/ confirm
Baby born from healthy mother COVID-19